Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 330

Should you buy CBA PERLS XII Capital Notes?

Commonwealth Bank of Australia (CBA) will raise $1.25bn via a Tier 1 hybrid issue, to be listed on the ASX, called CommBank PERLS XII Capital Notes. This issue will provide Additional Tier 1 (AT1) regulatory capital. The offer comprises a broker firm offer and an eligible securityholder offer. Unlike recent PERLS issues, this note is not a replacement of an existing issuance, hence there is no reinvestment offer.

CBAPI is a fully paid, convertible, transferrable, redeemable, subordinated, perpetual, unsecured note with a $100 face value and mandatory exchange date of 20 April 2029. Mandatory exchange is subject to several exchange conditions. CBAPI may be exchanged earlier as a result of a trigger event or CBA exercising an option to call the security two years early on 20 April 2027. Distributions are discretionary, noncumulative and fully franked with a dividend stopper. Distributions will be paid quarterly in arrears, based on the 90-day Bank Bill Swap (BBSW) rate plus a margin of 3.00% per year. For example, using the current 90-day BBSW rate of 0.85%, this equates to a gross running yield of 3.85% per year.

Key takeaways

  • We recommend investors subscribe to the offer for CBAPI. CBAPI’s issue margin of 3.00% provides a relatively attractive premium to our current fair value curve of major bank AT1 securities in the 7.5-year term to call range.
  • Following completion of the bookbuild, CBA has finalised the issue size at $1.25bn and a margin of 3.00%. Initially only seeking $750m and an indicative margin range of 3.00% to 3.20%, investor demand was clearly strong. The hunt for yield continues, triggered by low cash rates and growing expectations the RBA will cut further and even implement some form of quantitative easing in Australia.
  • Our near-term outlook for hybrid pricing remains constructive. The major banks are profitable, have strong AT1 capital positions and need to raise more Tier 2 Capital. Supply should remain tight in the near term, as corporate issuances have dried up with little signs of revival and major banks face a near-term shortage of AT1 reinvestment opportunities. Risks include a global backdrop of increased market volatility, or a major bank AT1 supply spike in the next six months should the banks take advantage of the prevailing low rate environment to execute large, long-dated deals.
  • It is important to reiterate hybrid securities should not be viewed as traditional fixed-income products, nor should they be considered a substitute for low-risk investments such as term deposits. We consider hybrid securities suitable only for investors with a medium to high risk tolerance due to their subordination on the capital structure.

Recommendation

We assign CBAPI a medium investment risk rating, the same as other Basel III-compliant Tier 1 major bank hybrids. The terms and conditions, such as nonviability and capital conversion triggers, in this new breed of hybrid securities make them more equity-like and, consequently, riskier than the “old-style” issues. Investors should understand these risks and be incrementally compensated in return. Nevertheless, for investors willing to take a position on the lower end of a company’s capital structure, hybrid securities can represent an attractive yield investment.

Domestic major bank AT1 hybrids have performed well since 2016, thanks to the search for yield amidst geopolitical/economic uncertainties, as well as record low interest rates globally. While the hybrid market has had a challenging close to 2018, 2019 has been very strong as markets embraced more risk following the Coalition’s victory in May. While average major bank trading margins moved out to 4.00% towards the end of 2018, they have just as rapidly recovered those price falls and at the time of writing sit around the 2.40% mark.

We believe a key reason for the CBAPI issue is to space out the maturity profile of the bank’s hybrids and avoid having clustered, mega deals as it did previously. With more than $14.5bn of major bank hybrids, of which around $6.1bn are CBA’s, due to be called in 2021–2022, future issues could: i) involve having to “outbid” issuers via higher margins; or ii) risk not being fully absorbed by the market. The more clustered the terms to call, the higher the refinancing risk.

Of the four major banks, National Australia Bank (NAB) has the biggest near-term refinancing needs, with both NABPB and NABPC due to be called in 2020. We expect NBA to refinance both hybrids in new issues in 2020, though it (or any other bank) could follow CBA’s lead and launch long-dated, “new money” issues early in order to pre-emptively meet APRA’s requirement for the major banks to have AT1 ratios of at least 1.5% by 2024. 

The timing of the CBAPI issue is practical, particularly given favourable funding conditions which are expected to persist. The distribution rate for hybrids are linked to the BBSW has plummeted over the course of 2019 following the repricing of cash rate expectations. The 90-day BBSW has more than halved from 2.08% at the start of January to around 0.85% currently.

Barring an unexpected bout of inflation, we do not envisage a spike in the BBSW in the near term given the RBA’s apparent intentions to ease monetary policy further.

From a capital ratio standpoint, we do not believe any of the major banks are in urgent need of additional AT1 capital, bearing in mind there are limited scheduled redemptions in 2020 (apart from NABPB and NABPC). All four major banks currently have enough AT1 capital, need to raise more Tier 2 capital (which are cheaper than AT1 hybrids) and meet common equity Tier 1 requirements in the near term. So, while near-term supply levels should remain tight, the prevailing low rate environment and strong investor appetite for yield could entice issuers to tap the market anyway.

Despite the relative attractiveness of CBA’s equity dividend yield premium to CBAPI’s yield to call, we still see value in CBAPI due to its lower expected volatility. As we have seen in recent years, hybrid volatility has been significantly lower than that of the equity of the same issuer. The latter bearing the brunt of the headline risks the major banks continue to face.

Exhibit 1: Major Banks AT1 hybrid call dates

Source: Morningstar

Exhibit 2: Major banks AT1 hybrid trading margins vs term to first call date

Source: Morningstar

Adam Fleck is Regional Director of Equity Research, Australia and NZ, and Shaun Ler is Associate, Equity & Credit Analyst, both at Morningstar Australasia. This article is general information and does not consider the circumstances of any investor. Please consultant a financial adviser before taking investment decisions.

 

RELATED ARTICLES

Is it time to sell bank hybrids?

Turbulence creates opportunities for bonds and hybrids

The dramatic tale of two hybrids, CBA VII versus VIII

banner

Most viewed in recent weeks

10 undervalued stocks if you're worried about volatility

Amid the coronavirus-induced turmoil, many quality names are trading at a discount to fair value, according to Morningstar analysts. A smaller list of companies also screen for earnings certainty.

Baseline outlook for economic recovery is too optimistic

We cannot throw our hands up in the air and say 'this time around, it's simply too hard'. Having no macro view is unhelpful, but many of the baseline scenarios are overly optimistic, says the former CEO of Westpac and now Chairman of Chi-X Australia.

What will stop the market returning to its highs?

Despite signs of optimism, market valuations are stretched and recovery is fuelled by government support. Some companies are doing well but stimulus cannot continue to prop up consumers for too long.

The most amazing investing lesson of all

If you had to choose one concept to explain to a young person setting out on an investment journey, it should be compounding. While the results are not as spectacular, it's especially relevant when returns are lower.

Will our government embrace these three reforms?

COVID-19 is an opportunity for a crucial policy reset, but what does that really mean? Business is hoping for three big reforms, but there are massive barriers to be overcome.

Welcome to Firstlinks Edition 357

There is a remarkable concentration similarity between the Australian and US stock markets that has delivered poor results for Australians and great results for Americans (and global investors). As the share prices of five Australian banks have tanked, the prices of five US technology companies have surged. Each group now represents 20% of their respective indexes, but the journey has been a disaster for many Australians.

  • 13 May 2020

Latest Updates

Strategy

Is it a myth that 'purpose' can drive corporate profits?

If ESG, ethical investing, philanthropy and CSR aren’t creating the magnitude of change needed, is there an alternative way of bridging the gap between profit growth and social benefit?

Investing

The most amazing investing lesson of all

If you had to choose one concept to explain to a young person setting out on an investment journey, it should be compounding. While the results are not as spectacular, it's especially relevant when returns are lower.

Economy

What will stop the market returning to its highs?

Despite signs of optimism, market valuations are stretched and recovery is fuelled by government support. Some companies are doing well but stimulus cannot continue to prop up consumers for too long.

Shares

Value is under pressure again - but its day will come

The key to investment success from here is the ability to ignore the crowd and the hot stocks. We will then face a once-in-a-lifetime chance to buy cyclical and industrial stocks with significant upside.

Investment strategies

10 undervalued stocks if you're worried about volatility

Amid the coronavirus-induced turmoil, many quality names are trading at a discount to fair value, according to Morningstar analysts. A smaller list of companies also screen for earnings certainty.

Gold

6 questions SMSF trustees are asking about gold

SMSF trustees are concerned about stock market volatility and low interest rates, and they asked six important questions during this seminar on whether gold has a role in their portfolios.

Exchange traded products

LIC fees banned but other doors remain open

Treasury has finally banned commissions paid to brokers and advisers on LICs and LITs but the exemption from FoFA rules remains for other listed products in the 'real' economy, whatever that is.

SMSF strategies

Is it the end of cash for SMSFs?

The simple message to diversify is not new, but thousands of SMSF trustees focus only on equities and dividends. COVID-19 is encouraging SMSFs to consider different investment strategies.

Sponsors

Alliances

© 2020 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use.
Any general advice or class service prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, has been prepared by without reference to your objectives, financial situation or needs. Refer to our Financial Services Guide (FSG) for more information. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.